Related Experiment Video
Updated: Nov 5, 2025

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Comprehensive management of major aphthous ulcer
Aravind Warrier1, Maguluru Sruthi2, K Anbarasi1
1Oral Medicine and Radiology, Sri Ramachandra Institute of Higher Education and Research, Chennai, India.
Major aphthous ulcers, a severe oral condition, can be challenging to treat. A multidisciplinary approach offers a long-term disease-free state for patients with recurrent aphthous ulcers.
Area of Science:
- Oral Medicine
- Dermatology
- Immunology
Background:
- Recurrent aphthous ulcers (RAU) are common oral mucosal diseases.
- Major aphthous ulcers (MAU) are a less frequent, refractory subtype of RAU.
- MAU can persist for months, significantly impacting patient health.
Observation:
- A case study of an adolescent male with multiple, persistent oral ulcers is presented.
- The patient experienced ulcers for 10 months despite conventional topical treatments.
- Three simultaneous ulcers were observed in the patient.
Findings:
- A multidisciplinary treatment approach was implemented for the patient.
- This comprehensive strategy led to a long-term disease-free state.
- The treatment effectively managed the refractory nature of the major aphthous ulcers.
Implications:
- The presented multidisciplinary treatment model can be adopted by healthcare professionals.
- This approach may offer a successful management strategy for refractory oral ulcers.
- Effective management of major aphthous ulcers can improve patient quality of life.
More Related Videos
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

